/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Bausch Health Companies Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$7 0.0217(2.17%) BHC at 04 Dec 2025 04:26 PM Drug Manufacturers - Specialty & Generic
Lowest Today 6.83
Highest Today 7.06
Today’s Open 6.95
Prev. Close 6.9
52 Week High 8.69
52 Week Low 4.25
Day’s Range: Low 6.83 High 7.06
52-Week Range: Low 4.25 High 8.69
1 day return -
1 Week return +11.29
1 month return +4.29
3 month return -2.28
6 month return +51.66
1 year return -13.45
3 year return -6.81
5 year return -64.59
10 year return -

Institutional Holdings

ICAHN CARL C 9.39

Goldentree Asset Management LP 9.26

Paulson & Company Inc 8.87

Nomura Holdings Inc 5.81

HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 3.52

Vanguard Group Inc 3.18

Royal Bank of Canada 2.53

Maple Rock Capital Partners, Inc. 2.11

SG Americas Securities, LLC 1.66

MFN Partners Management, LP 1.62

Kohlberg Kravis Roberts & Co LP 1.42

Macquarie Group Ltd 1.38

Hudson Bay Capital Management LP 1.35

ING Groep NV 1.35

Vanguard Total Intl Stock Index Inv 1.14

Mitsubishi UFJ Securities International PLC 0.92

Dimensional Fund Advisors, Inc. 0.82

BNP Paribas Arbitrage, SA 0.81

Vanguard Developed Markets Index Admiral 0.72

Vanguard Instl Ttl Intl Stk Mkt Idx TrII 0.59

Arrowstreet Capital Limited Partnership 0.48

Charles Schwab Investment Management Inc 0.43

DFA International Small Company I 0.40

Private Management Group Inc 0.39

iShares Core S&P/TSX Capped Compost ETF 0.38

Fidelity Canadian Value ETF 0.33

Vanguard FTSE All-Wld ex-US SmCp Idx Ins 0.26

Schwab Fundamental International Eq ETF 0.24

BMO S&P/TSX Capped Composite ETF 0.23

Vanguard FTSE Canada All Cap ETF 0.21

State St Gbl Sm Cp Eq ex-US Indx NL Cl A 0.21

RBC O'Shaughnessy Canadian Eqty Fund A 0.16

BLK CDN MSCI Can IMI Ext ESG Fcs Idx A 0.16

Schwab International Small-Cap Eq ETF™ 0.15

DFA International Core Equity 2 I 0.14

TD Emerald Canadian Equity Index 0.13

RBC QUBE Canadian Equity F 0.12

Dimensional International Small Cap ETF 0.10

iShares Core MSCI Total Intl Stk ETF 0.10

SPDR® Portfolio Developed Wld ex-US ETF 0.10

Market Status

Strong Buy: 0

Buy: 1

Hold: 5

Sell: 1

Strong Sell: 0

Fundamentals

Market Cap 2559.55 M

PB Ratio 18.7773

PE Ratio 7.1134

Enterprise Value 22354.22 M

Total Assets 26523.00 M

Volume 3230753

Company Financials

Annual Revenue FY24:9518000000 9518.0M, FY23:8542000000 8542.0M, FY22:8124000000 8124.0M, FY21:8434000000 8434.0M, FY20:8027000000 8027.0M

Annual Profit FY24:6736000000 6736.0M, FY23:6036000000 6036.0M, FY22:5760000000 5760.0M, FY21:6040000000 6040.0M, FY20:5778000000 5778.0M

Annual Net worth FY24:-46000000 -46.0M, FY23:-963000000 -963.0M, FY22:-212000000 -212.0M, FY21:-937000000 -937.0M, FY20:-559000000 -559.0M

Quarterly Revenue Q3/2025:912000000 912.0M, Q2/2025:2530000000 2530.0M, Q1/2025:2259000000 2259.0M, Q4/2024:2559000000 2559.0M, Q3/2024:2510000000 2510.0M

Quarterly Profit Q3/2025:1580000000 1580.0M, Q2/2025:1766000000 1766.0M, Q1/2025:1558000000 1558.0M, Q4/2024:1832000000 1832.0M, Q3/2024:1532197278 1532.2M

Quarterly Net worth Q3/2025:179000000 179.0M, Q2/2025:148000000 148.0M, Q1/2025:-58000000 -58.0M, Q4/2024:93000000 93.0M, Q3/2024:-85000000 -85.0M

Fund house & investment objective

Company Information Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Organisation Drug Manufacturers - Specialty & Generic

Employees 20700

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Thomas J. Appio

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow